✦ LIBER ✦

Dopamine transporter imaging

✍ Scribed by Andrew J. Lees; Donald G. Grosset

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 32 KB
Volume: 18
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.10570

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of dopamine transporter imaging in

Role of dopamine transporter imaging in routine clinical practice

✍ Vicky Marshall; Donald Grosset 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 301 KB

## Abstract Functional imaging of the dopamine transporter (DAT) defines integrity of the dopaminergic system and has its main clinical application in patients with mild, incomplete, or uncertain parkinsonism. Imaging with specific single positron emission computerised tomography ligands for DAT (F

The effect of dopamine agonist therapy o

The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease

✍ J. Eric Ahlskog; Ryan J. Uitti; Michael K. O'Connor; Demetrius M. Maraganore; Jo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

Role of dopamine transporter imaging in

Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders

✍ Vicky Marshall; Donald G. Grosset 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

Dopamine transporter (DAT) imaging detects presynaptic dopamine neuronal dysfunction and thereby assists differentiation of conditions with and without dopamine deficit. In atypical tremor disorders, DAT imaging can differentiate between Parkinson's disease (PD), where dopamine deficit is demonstrat

Dementia with Lewy bodies versus Alzheim

Dementia with Lewy bodies versus Alzheimer's disease: Role of dopamine transporter imaging

✍ Durval C. Costa; Zuzana Walker; Rodney W.H. Walker; Flávia R.G. Fontes 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

Altropane, a SPECT or PET imaging probe

Altropane, a SPECT or PET imaging probe for dopamine neurons: I. dopamine transporter binding in primate brain

✍ Bertha K. Madras; Peter C. Meltzer; Anna Y. Liang; David R. Elmaleh; John Babich 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

Increasing evidence suggests that the dopamine transporter is an important marker for physiological and pathological changes in dopamine neurons. Potent dopamine transport inhibitors of the phenyltropane series (e.g., WIN 35,428 or CFT) are particularly suitable for PET (positron emission tomography

Fluorine-18-labeled tropane analogs for

Fluorine-18-labeled tropane analogs for PET imaging studies of the dopamine transporter

✍ Robert H. Mach; Michael A. Nader; Richard L. Ehrenkaufer; H. Donald Gage; Steven 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB

A series of PET imaging studies were conducted with two fluorine-18-labeled tropane analoges, [(18)F](+)-FTT and [(18)F](+)-FCT. Both compounds possessed a high affinity and selectivity for the dopamine transporter and had a higher accumulation in the basal ganglia, a brain region having a high dens